Individual-level harm reduction intervention coverage among people in Australia who inject drugs
Bibliographic Data
| ID | 14907598 |
|---|---|
| Authors | Olivia Price (0000-0002-2259-735X, UNSW Sydney), Daniel O’Keefe (0000-0001-6799-2372, Burnet Institute), Samantha Colledge‐Frisby (0000-0003-3571-0136, Monash Health), Rachel Sutherland (0000-0003-0470-7663, UNSW Sydney), Paul Dietze (0000-0001-7871-6234, National Trauma Research Institute), Raimondo Bruno (0000-0001-6673-833X, University of Tasmania), Louisa Degenhardt (0000-0002-8513-2218, UNSW Sydney), Amy Peacock (0000-0002-5705-2026, University of Tasmania, corresponding author) |
| Year | 2025 |
| Volume | 145 |
| Pages | 105023 |
| Publication date | 2025-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2025.105023 |
| PMID | 41072118 |
| OpenAlex | W4415043767 |
| Language | EN |
| Citations received | 2 |
| References cited | 28 |
Individual-level needle/syringe and OAT coverage among people who inject drugs in Australian capital cities is high relative to targets, but there are gaps in the implementation of THN. Despite high syringe coverage, a notable minority reported needle/syringe reuse
Capital (architecture · Harm · Harm reduction · Intervention (counseling · Occupational safety and health · Suicide prevention · Syringe · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Opioid Use Disorder Treatment
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs
The Severity of Dependence Scale (SDS)
Alternatives for logistic regression in cross-sectional studies
Epidemiology of acute infections in people who inject drugs in Australia
Health service utilisation and access for people who inject drugs during Covid ‐19
Opioid agonist treatment and patient outcomes during the Covid ‐19 pandemic in south east Sydney, Australia
Trends in methamphetamine use, markets and harms in Australia, 2003–2019
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage
The ‘risk environment’
Naloxone cascade of care among people who regularly inject drugs in Australia, 2020–2022
You'll come in and dose even in a global pandemic”
| Unique citing works | 2 |
|---|---|
| Citations per year | 2 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |